Historical salary details - Mr. Franklin M. Berger, C.F.A., Independent Director, Essa Pharma Inc
Mr. Franklin M. Berger, C.F.A. is the Independent Director of Essa Pharma Inc. They also hold 1 other positions in and Atea Pharmaceuticals Inc.
Mr. Franklin M. Berger, C.F.A.
Independent Director
$ 504.4 K
Gross Remuneration
-
Current Company
Essa Pharma Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Essa Pharma Inc | Independent Director | 504.4 K | 834.1 % |
| 2024 | Atea Pharmaceuticals Inc | Lead Independent Director | - | - |
| 2023 | Atea Pharmaceuticals Inc | Lead Independent Director | 357.1 K | -3.0 % |
| 2023 | Kezar Life Sciences Inc | Independent Director | 141.2 K | -3.3 % |
| 2023 | Essa Pharma Inc | Independent Director | 54 K | -28.3 % |
| 2022 | Atea Pharmaceuticals Inc | Lead Independent Director | 368.2 K | -40.9 % |
| 2022 | Kezar Life Sciences Inc | Independent Director | 146.0 K | -4.2 % |
| 2022 | Rain Oncology Inc | Lead Independent Director | 117.8 K | - |
| 2022 | Essa Pharma Inc | Independent Director | 75.3 K | -52.3 % |
| 2022 | Atreca Inc - Ordinary Shares - Class A | Independent Director | 71.8 K | -49.1 % |
| 2021 | Atea Pharmaceuticals Inc | Lead Independent Director | 622.7 K | -55.8 % |
| 2021 | Essa Pharma Inc | Independent Director | 157.8 K | -14.9 % |
| 2021 | Kezar Life Sciences Inc | Independent Director | 152.4 K | 76.9 % |
| 2021 | Atreca Inc - Ordinary Shares - Class A | Independent Director | 141.0 K | -31.8 % |
| 2020 | Atea Pharmaceuticals Inc | Lead Independent Director | 1.4 M | 4167.3 % |
| 2020 | Atreca Inc - Ordinary Shares - Class A | Independent Director | 206.7 K | 400.7 % |
| 2020 | Essa Pharma Inc | Independent Director | 185.4 K | - |
| 2020 | Kezar Life Sciences Inc | Independent Director | 86.2 K | -11.5 % |
| 2019 | Applied Therapeutics Inc | Independent Director | 114.2 K | 338.4 % |
| 2019 | Kezar Life Sciences Inc | Independent Director | 97.4 K | 54.1 % |
| 2019 | Atreca Inc - Ordinary Shares - Class A | Independent Director | 41.3 K | 65.1 % |
| 2019 | Atea Pharmaceuticals Inc | Lead Independent Director | 33.0 K | - |
| 2019 | Essa Pharma Inc | Independent Director | - | - |
| 2018 | Kezar Life Sciences Inc | Independent Director | 63.2 K | 139.4 % |
| 2018 | Applied Therapeutics Inc | Independent Director | 26.1 K | - |
| 2018 | Atreca Inc - Ordinary Shares - Class A | Independent Director | 25 K | - |
| 2018 | Essa Pharma Inc | Independent Director | - | - |
| 2017 | Kezar Life Sciences Inc | Independent Director | 26.4 K | - |
| 2017 | Essa Pharma Inc | Independent Director | - | - |
| 2016 | Essa Pharma Inc | Independent Director | - | - |
| 2015 | Essa Pharma Inc | Independent Director | - | - |
| 2014 | Essa Pharma Inc | Director | - | - |